Transcriptomic analyses of neurotoxic effects in mouse brain after intermittent neonatal administration of thimerosal

Toxicological Sciences

Volumn 139, Issue 2, 2014, Pages 452-465

  Li, Xiaoling ^a   Qu, Fengqin ^a   Xie, Wenjuan ^a   Wang, Fengli ^a   Liu, Hongmei ^a   Song, Shuhui ^b   Chen, Tingting ^b   Zhang, Yang ^a   Zhu, Shu ^a   Wang, Yun ^a   Guo, Caixia ^b   Tang, Tie Shan ^a  

^a INSTITUTE OF ZOOLOGY   (China)

^b Chinese Academy of Sciences   (China)

Author keywords

Anterior pituitary; Autistic disorder; Hormone; Neurotoxicity; Thimerosal; Transcriptomic analyses

Indexed keywords

THIOMERSAL; PRESERVATIVE; TRANSCRIPTOME;

ADENOHYPOPHYSIS; ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTISM; CONTROLLED STUDY; DEPRESSION; ENVIRONMENTAL FACTOR; FEMALE; GENDER BIAS; HIGH THROUGHPUT SEQUENCING; HUMAN; MALE; MOUSE; NERVE CELL DIFFERENTIATION; NEUROPATHOLOGY; NEUROTOXICITY; NEWBORN; NONHUMAN; PRESYNAPTIC NERVE; RNA SEQUENCE; SOCIAL INTERACTION; TRANSCRIPTOMICS; ANIMAL; BRAIN; DOSE RESPONSE; DRUG EFFECTS; GENE EXPRESSION PROFILING; GROWTH, DEVELOPMENT AND AGING; INBRED MOUSE STRAIN; NEUROTOXICITY SYNDROMES; PATHOLOGY; PSYCHOLOGY; SEXUAL DEVELOPMENT; TOXICITY;

ANIMALS; ANIMALS, NEWBORN; BEHAVIOR, ANIMAL; BRAIN; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GENE EXPRESSION PROFILING; MALE; MICE, INBRED STRAINS; NEUROTOXICITY SYNDROMES; PRESERVATIVES, PHARMACEUTICAL; SEX CHARACTERISTICS; THIMEROSAL; TRANSCRIPTOME;

EID: 84899979513     PISSN: 10966080     EISSN: 10960929     Source Type: Journal    
DOI: 10.1093/toxsci/kfu049     Document Type: Article

References (78)

1. American Academy of Pediatrics and United States Public Health Service (1999). Joint statement of the American Academy of Pediatrics (AAP) and the United States Public Health Service (USPHS). Pediatrics 104(3 Pt 1), 568-569.
2. Aprea, J., Prenninger, S., Dori, M., Ghosh, T., Monasor, L. S., Wessendorf, E., Zocher, S., Massalini, S., Alexopoulou, D., Lesche, M., et al. (2013). Transcriptome sequencing during mouse brain development identifies long noncoding RNAs functionally involved in neurogenic commitment. EMBO J. 32, 3145-3160.
3. Araghi-Niknam, M., and Fatemi, S. H. (2003). Levels of Bcl-2 and P53 are altered in superior frontal and cerebellar cortices of autistic subjects. Cell. Mol. Neurobiol. 23, 945-952.
4. Arias-Carrion, O., and Poppel, E. (2007). Dopamine, learning, and rewardseeking behavior. Acta Neurobiol. Exp. 67, 481-488.
5. Ball, L. K., Ball, R., and Pratt, R. D. (2001). An assessment of thimerosal use in childhood vaccines. Pediatrics 107, 1147-1154.
6. Bangash, M. A., Park, J. M., Melnikova, T., Wang, D., Jeon, S. K., Lee, D., Syeda, S., Kim, J., Kouser, M., Schwartz, J., et al. (2011). Enhanced polyubiquitination of Shank3 and NMDA receptor in a mouse model of autism. Cell 145, 758-772.
7. Berman, R. F., Pessah, I. N., Mouton, P. R.,Mav, D., and Harry, J. (2008). Lowlevel neonatal thimerosal exposure: Further evaluation of altered neurotoxic potential in SJL mice. Toxicol. Sci. 101, 294-309.
8. Bernard, S., Enayati, A., Redwood, L., Roger, H., and Binstock, T. (2001). Autism: A novel form of mercury poisoning. Med. Hypotheses 56, 462-471.
9. Black, C., Kaye, J. A., and Jick, H. (2002). Relation of childhood gastrointestinal disorders to autism: Nested case-control study using data from the UK General Practice Research Database. BMJ 325, 419-421.
10. Blaxill, M. F., Redwood, L., and Bernard, S. (2004). Thimerosal and autism? A plausible hypothesis that should not be dismissed. Med. Hypotheses 62, 788-794.
11. Bultynck, G., Szlufcik, K., Kasri, N. N., Assefa, Z., Callewaert, G., Missiaen, L., Parys, J. B., and De Smedt, H. (2004). Thimerosal stimulates Ca2+ flux through inositol 1,4,5-trisphosphate receptor type 1, but not type 3, via modulation of an isoform-specific Ca2+-dependent intramolecular interaction. Biochem. J. 381(Pt 1), 87-96.
12. Centers for Disease Control and Prevention (CDC) (1999). Thimerosal in vaccines: A joint statement of the American Academy of Pediatrics and the Public Health Service. MMWR Morb. Mortal. Wkly. Rep. 48, 563-565.
13. Chakrabarti, S., and Fombonne, E. (2001). Pervasive developmental disorders in preschool children. JAMA 285, 3093-3099.
14. Courchesne, E., Mouton, P. R., Calhoun, M. E., Semendeferi, K., Ahrens- Barbeau, C., Hallet, M. J., Barnes, C. C., and Pierce, K. (2011). Neuron number and size in prefrontal cortex of children with autism. JAMA 306, 2001- 2010.
15. Dallman, M. F., Akana, S. F., Strack, A. M., Scribner, K. S., Pecoraro, N., La Fleur, S. E., Houshyar, H., and Gomez, F. (2004). Chronic stress-induced effects of corticosterone on brain: Direct and indirect. Ann. N. Y. Acad. Sci. 1018, 141-150.
16. Dorea, J. G. (2007). Exposure to mercury during the first six months via human milk and vaccines: Modifying risk factors. Am. J. Perinatol. 24, 387-400.
17. Dorea, J. G., Marques, R. C., and Brandao, K. G. (2009) Neonate exposure to thimerosal mercury from hepatitis B vaccines.. Am. J. Perinatol., 26, 523- 527.
18. Gallagher, C. M., and Goodman, M. S. (2010). Hepatitis B vaccination of male neonates and autism diagnosis, NHIS 1997-2002. J. Toxicol. Environ. Health A 73, 1665-1677.
19. Geier,D. A., andGeier,M. R. (2003).An assessment of the impact of thimerosal on childhood neurodevelopmental disorders. Pediatr. Rehabil. 6, 97-102.
20. Geier, D. A., and Geier, M. R. (2004). A comparative evaluation of the effects ofMMRimmunization and mercury doses from thimerosal-containing childhood vaccines on the population prevalence of autism. Med. Sci. Monit. 10, PI33-39.
21. Geier,D. A., andGeier,M. R. (2005).A two-phased population epidemiological study of the safety of thimerosal-containing vaccines: A follow-up analysis. Med. Sci. Monit. 11, CR160-170.
22. Geier, D. A., and Geier, M. R. (2006a). An assessment of downward trends in neurodevelopmental disorders in the United States following removal of Thimerosal from childhood vaccines. Med. Sci. Monit. 12, CR231-239.
23. Geier, D. A., and Geier, M. R. (2006b). A meta-analysis epidemiological assessment of neurodevelopmental disorders following vaccines administered from 1994 through 2000 in the United States. Neuro Endocrinol. Lett. 27, 401-413.
24. Gerra, G., Zaimovic, A., Zambelli, U., Timpano, M., Reali, N., Bernasconi, S., and Brambilla, F. (2000). Neuroendocrine responses to psychological stress in adolescents with anxiety disorder. Neuropsychobiology 42, 82-92.
25. Geschwind, D. H., and Levitt, P. (2007). Autism spectrum disorders: Developmental disconnection syndromes. Curr. Opin. Nneurobiol. 17, 103-111.
26. Gilbert, S. J., Bird, G., Brindley, R., Frith, C. D., and Burgess, P. W. (2008). Atypical recruitment of medial prefrontal cortex in autism spectrum disorders: An fMRI study of two executive function tasks. Neuropsychologia 46, 2281-2291.
27. Guzowski, J. F., Lyford,G. L., Stevenson, G. D., Houston, F. P., McGaugh, J. L., Worley, P. F., and Barnes, C. A. (2000). Inhibition of activity-dependent arc protein expression in the rat hippocampus impairs the maintenance of longterm potentiation and the consolidation of long-term memory. J. Neurosci. 20, 3993-4001.
28. Hallmayer, J., Cleveland, S., Torres, A., Phillips, J., Cohen, B., Torigoe, T., Miller, J., Fedele, A., Collins, J., Smith, K., et al. (2011). Genetic heritability and shared environmental factors among twin pairs with autism. Arch. Gen. Psychiatry 68, 1095-1102.
29. Heron, J., and Golding, J. (2004). Thimerosal exposure in infants and developmental disorders: A prospective cohort study in the United kingdom does not support a causal association. Pediatrics 114, 577-583.
30. Hertz-Picciotto, I., and Delwiche, L. (2009). The rise in autism and the role of age at diagnosis. Epidemiology 20, 84-90.
31. Hewitson, L., Lopresti, B. J., Stott, C., Mason, N. S., and Tomko, J. (2010). Influence of pediatric vaccines on amygdala growth and opioid ligand binding in rhesus macaque infants: A pilot study. Acta Neurobiol. Exp. 70, 147-164.
32. Hornig,M., Chian, D., and Lipkin, W. I. (2004). Neurotoxic effects of postnatal thimerosal are mouse strain dependent. Mol. Psychiatry 9, 833-845.
33. Hviid, A., Stellfeld, M., Wohlfahrt, J., and Melbye, M. (2003). Association between thimerosal-containing vaccine and autism. JAMA 290, 1763-1766.
34. Immunization Safety Review Committee (2004). Immunization Safety Review: Vaccines and Autism. National Academies Press, Washington, DC.
35. Iwata, K., Matsuzaki, H., Miyachi, T., Shimmura, C., Suda, S., Tsuchiya, K. J., Matsumoto, K., Suzuki, K., Iwata, Y., Nakamura, K., et al. (2011). Investigation of the serum levels of anterior pituitary hormones in male children with autism. Mol. Autism 2, 16.
36. Jung, N. H., Janzarik, W. G., Delvendahl, I., Munchau, A., Biscaldi, M., Mainberger, F., Baumer, T., Rauh, R., and Mall, V. (2013). Impaired induction of long-term potentiation-like plasticity in patients with high-functioning autism and Asperger syndrome. Dev. Med. Child Neurol. 55, 83-89.
37. Kern, J. K., Geier, D. A., Audhya, T., King, P. G., Sykes, L. K., and Geier, M. R. (2012). Evidence of parallels between mercury intoxication and the brain pathology in autism. Acta Neurobiol. Exp. 72, 113-153.
38. Kovesdi, E., Pal, J., and Gallyas, F. (2007). The fate of "dark" neurons produced by transient focal cerebral ischemia in a non-necrotic and non-excitotoxic environment: Neurobiological aspects. Brain Res. 1147, 272-283.
39. Laurente, J., Remuzgo, F., Ávalos, B., Chiquinta, J., Ponce, B., Avendano, R., and Maya, L. (2007). Neurotoxic effects of thimerosal at vaccines doses on the encephalon and development in 7 days-old hamsters. An. Fac. Med. (Lima) 68, 222-237.
40. Madsen, K. M., Lauritsen, M. B., Pedersen, C. B., Thorsen, P., Plesner, A. M., Andersen, P. H., andMortensen, P. B. (2003). Thimerosal and the occurrence of autism: Negative ecological evidence from Danish population-based data. Pediatrics 112(3 Pt 1), 604-606.
41. Majewska, M. D., Urbanowicz, E., Rok-Bujko, P., Namyslowska, I., and Mierzejewski, P. (2010). Age-dependent lower or higher levels of hair mercury in autistic children than in healthy controls. Acta Neurobiol. Exp. 70, 196-208.
42. Massey, P. V., Johnson, B. E., Moult, P. R., Auberson, Y. P., Brown, M. W., Molnar, E., Collingridge, G. L., and Bashir, Z. I. (2004). Differential roles of NR2A and NR2B-containing NMDA receptors in cortical long-term potentiation and long-term depression. J. Neurosci. 24, 7821-7828.
43. McFadden, K., andMinshew, N. J. (2013). Evidence for dysregulation of axonal growth and guidance in the etiology of ASD. Front. Hum. Neurosci. 7, 671.
44. Mutter, J., Naumann, J., Schneider, R., Walach, H., and Haley, B. (2005). Mercury and autism: Accelerating evidence? Neuro Endocrinol. Lett. 26, 439- 446.
45. Nelson, K. B., and Bauman, M. L. (2003). Thimerosal and autism? Pediatrics 111, 674-679.
46. Nicolson, R., DeVito, T. J., Vidal, C. N., Sui, Y., Hayashi, K. M., Drost, D. J., Williamson, P. C., Rajakumar, N., Toga, A.W., and Thompson, P. M. (2006). Detection and mapping of hippocampal abnormalities in autism. Psychiatry Res. 148, 11-21.
47. Olczak, M., Duszczyk, M., Mierzejewski, P., and Majewska, M. D. (2009). Neonatal administration of a vaccine preservative, thimerosal, produces lasting impairment of nociception and apparent activation of opioid system in rats. Brain Res. 1301, 143-151.
48. Olczak, M., Duszczyk, M., Mierzejewski, P., Meyza, K., and Majewska, M. D. (2011). Persistent behavioral impairments and alterations of brain dopamine system after early postnatal administration of thimerosal in rats. Behav. Brain Res. 223, 107-118.
49. Olczak, M., Duszczyk, M., Mierzejewski, P., Wierzba-Bobrowicz, T., and Majewska, M. D. (2010). Lasting neuropathological changes in rat brain after intermittent neonatal administration of thimerosal. Folia Neuropathol. 48, 258- 269.
50. Pless, R., and Risher, J. F. (2000). Mercury, infant neurodevelopment, and vaccination. J. Pediatr. 136, 571-573.
51. Poirier, M., Martin, J. S., Gaigg, S. B., and Bowler, D. M. (2011). Short-term memory in autism spectrum disorder. J. Abnorm. Psychol. 120, 247-252.
52. Preston, A. R., and Eichenbaum, H. (2013). Interplay of hippocampus and prefrontal cortex in memory. Curr. Biol. 23, R764-R773.
53. Qvarnstrom, J., Lambertsson, L., Havarinasab, S., Hultman, P., and Frech, W. (2003). Determination of methylmercury, ethylmercury, and inorganic mercury in mouse tissues, following administration of thimerosal, by speciesspecific isotope dilution GC-inductively coupled plasma-MS. Anal. Chem. 75, 4120-4124.
54. Raymond, G. V., Bauman, M. L., and Kemper, T. L. (1996). Hippocampus in autism: A Golgi analysis. Acta Neuropathol. 91, 117-119.
55. Rodin, E., Subramanian, M. G., and Gilroy, J. (1984). Investigation of sex hormones in male epileptic patients. Epilepsia 25, 690-694.
56. Rojas, D. C., Smith, J. A., Benkers, T. L., Camou, S. L., Reite, M. L., and Rogers, S. J. (2004). Hippocampus and amygdala volumes in parents of children with autistic disorder. Am. J. Psychiatry 161, 2038-2044.
57. Saitoh, O., Karns, C. M., and Courchesne, E. (2001). Development of the hippocampal formation from 2 to 42 years: MRI evidence of smaller area dentata in autism. Brain 124(Pt 7), 1317-1324.
58. Salmond, C. H., Ashburner, J., Connelly, A., Friston, K. J., Gadian, D. G., and Vargha-Khadem, F. (2005). The role of the medial temporal lobe in autistic spectrum disorders. Eur. J. Neurosci. 22, 764-772.
59. Sato, D., Lionel, A. C., Leblond, C. S., Prasad, A., Pinto, D., Walker, S., O'Connor, I., Russell, C., Drmic, I. E., Hamdan, F. F., et al. (2012). SHANK1 deletions in males with autism spectrum disorder. Am. J. Hum. Genet. 90, 879-887.
60. Schumann, C. M., Hamstra, J., Goodlin-Jones, B. L., Lotspeich, L. J., Kwon, H., Buonocore, M. H., Lammers, C. R., Reiss, A. L., and Amaral, D. G. (2004). The amygdala is enlarged in children but not adolescents with autism; the hippocampus is enlarged at all ages. J. Neurosci. 24, 6392-6401.
61. Stehr-Green, P., Tull, P., Stellfeld, M., Mortenson, P. B., and Simpson, D. (2003). Autism and thimerosal-containing vaccines: Lack of consistent evidence for an association. Am. J. Prev.Med. 25, 101-106.
62. Strekalova, T., and Steinbusch, H.W. (2010).Measuring behavior in mice with chronic stress depression paradigm. Prog. Neuro-psychopharmacol. Biol. Psychiatry 34, 348-361.
63. Sweeten, T. L., Bowyer, S. L., Posey, D. J., Halberstadt, G. M., and McDougle, C. J. (2003). Increased prevalence of familial autoimmunity in probands with pervasive developmental disorders. Pediatrics 112, e420.
64. Sweeten, T. L., Posey, D. J., Shekhar, A., and McDougle, C. J. (2002). The amygdala and related structures in the pathophysiology of autism. Pharmacol. Biochem. Behav. 71, 449-455.
65. Thompson, W. W., Price, C., Goodson, B., Shay, D. K., Benson, P., Hinrichsen, V. L., Lewis, E., Eriksen, E., Ray, P., Marcy, S. M, et al. (2007). Early thimerosal exposure and neuropsychological outcomes at 7 to 10 years. N. Engl. J. Med. 357, 1281-1292.
66. Torres, A. R., Maciulis, A., Stubbs, E. G., Cutler, A., and Odell, D. (2002). The transmission disequilibrium test suggests that HLA-DR4 and DR13 are linked to autism spectrum disorder. Hum. Immunol. 63, 311-316.
67. Tripodianakis, J., Markianos, M., Rouvali, O., and Istikoglou, C. (2007). Gonadal axis hormones in psychiatric male patients after a suicide attempt. Eur. Arch. Psychiatry Clin. Neurosci. 257, 135-139.
68. Verstraeten, T., Davis, R. L., DeStefano, F., Lieu, T. A., Rhodes, P. H., Black, S. B., Shinefield, H., and Chen, R. T. (2003). Safety of thimerosal-containing vaccines: A two-phased study of computerized health maintenance organization databases. Pediatrics 112, 1039-1048.
69. Voineagu, I., Wang, X., Johnston, P., Lowe, J. K., Tian, Y., Horvath, S., Mill, J., Cantor, R. M., Blencowe, B. J., and Geschwind, D. H. (2011). Transcriptomic analysis of autistic brain reveals convergent molecular pathology. Nature 474, 380-384.
70. Wallace, G. L., Shaw, P., Lee, N. R., Clasen, L. S., Raznahan, A., Lenroot, R. K., Martin, A., and Giedd, J. N. (2012). Distinct cortical correlates of autistic versus antisocial traits in a longitudinal sample of typically developing youth. J. Neurosci. 32, 4856-4860.
71. Wang, L., Feng, Z., Wang, X., Wang, X., and Zhang, X. (2010). DEGseq: An R package for identifying differentially expressed genes from RNA-seq data. Bioinformatics 26, 136-138.
72. Wang, F., Yang, Y., Lin, X., Wang, J. Q., Wu, Y. S., Xie, W., Wang, D., Zhu, S., Liao, Y. Q., Sun, Q., et al. (2013). Genome-wide loss of 5-hmC is a novel epigenetic feature of Huntington's disease. Hum. Mol. Genet. 22, 3641-3653.
73. Werling, D. M., and Geschwind, D. H. (2013). Sex differences in autism spectrum disorders. Curr. Opin. Neurol. 26, 146-153.
74. WHO IRIS (2002). Vaccines and biologicals. Recommendations from the Strategic Advisory Group of Experts. Wkly. Epidemiol. Rec. 77, 305-311.
75. Yang, M., Silverman, J. L., and Crawley, J. N. (2011). Automated threechambered social approach task for mice. Curr. Protoc. Neurosci. Chapter 8, Unit 8 26. (editorial board, Jacqueline N. Crawley, etc.).
76. Young, H. A., Geier, D. A., and Geier, M. R. (2008). Thimerosal exposure in infants and neurodevelopmental disorders: An assessment of computerized medical records in the Vaccine Safety Datalink. J. Neurol. Sci. 271, 110-118.
77. Zhang, J. (1984). Clinical observations in ethyl mercury chloride poisoning. Am. J. Ind. Med. 5, 251-258.
78. Zhao, W., Liu, W., Tian, D., Tang, B., Wang, Y., Yu, C., Li, R., Ling, Y., Wu, J., Song, S., and Hu, S. (2011). wapRNA: A web-based application for the processing of RNA sequences. Bioinformatics 27, 3076-3077.